Novartis In-Kind Collaborator

The Cleary laboratory studies the molecular pathogenesis of cancer. They have discovered several genes that are damaged by chromosomal translocations in human leukemias. They are currently investigating the normal functions of these genes and their contributions to cancer employing a variety of experimental approaches that include biochemical techniques and in vitro cellular transformation assays as well as genetic analyses using transgenic and knockout mouse models.